Next Article in Journal
Early Prediction Model of Macrosomia Using Machine Learning for Clinical Decision Support
Next Article in Special Issue
Ultrasound and Clinical Alterations in the Foot of Children with Obesity and Diabetes
Previous Article in Journal
DSCNet: Deep Skip Connections-Based Dense Network for ALL Diagnosis Using Peripheral Blood Smear Images
Previous Article in Special Issue
B Cell Lymphocytosis in Juvenile Dermatomyositis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome

1
Division of Gastroenterology, Hepatology & Nutrition, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115, USA
2
Hepatogastroenterology, Rehabilitative Nutrition, Digestive Endoscopy and Liver Transplant Unit, ERN RARE LIVER, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy
3
Pediatric Department and Transplantation, ISMETT, 90133 Palermo, Italy
*
Author to whom correspondence should be addressed.
Diagnostics 2023, 13(17), 2753; https://doi.org/10.3390/diagnostics13172753
Submission received: 11 July 2023 / Revised: 11 August 2023 / Accepted: 13 August 2023 / Published: 24 August 2023

Abstract

Juvenile autoimmune hepatitis (JAIH) is severe immune-mediated necro-inflammatory disease of the liver with spontaneous progression to cirrhosis and liver failure if left untreated. The diagnosis is based on the combination of clinical, laboratory and histological findings. Prothrombin ratio is a useful prognostic factor to identify patients who will most likely require a liver transplant by adolescence or early adulthood. JAIH treatment consists of immune suppression and should be started promptly at diagnosis to halt inflammatory liver damage and ultimately prevent fibrosis and progression to end-stage liver disease. The risk of relapse is high especially in the setting of poor treatment compliance. Recent evidence however suggests that treatment discontinuation is possible after a prolonged period of normal aminotransferase activity without the need for liver biopsy prior to withdrawal.
Keywords: autoimmune hepatitis; acute liver failure; autoimmune liver disease; active chronic hepatitis liver transplantation autoimmune hepatitis; acute liver failure; autoimmune liver disease; active chronic hepatitis liver transplantation

Share and Cite

MDPI and ACS Style

Nastasio, S.; Mosca, A.; Alterio, T.; Sciveres, M.; Maggiore, G. Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome. Diagnostics 2023, 13, 2753. https://doi.org/10.3390/diagnostics13172753

AMA Style

Nastasio S, Mosca A, Alterio T, Sciveres M, Maggiore G. Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome. Diagnostics. 2023; 13(17):2753. https://doi.org/10.3390/diagnostics13172753

Chicago/Turabian Style

Nastasio, Silvia, Antonella Mosca, Tommaso Alterio, Marco Sciveres, and Giuseppe Maggiore. 2023. "Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome" Diagnostics 13, no. 17: 2753. https://doi.org/10.3390/diagnostics13172753

APA Style

Nastasio, S., Mosca, A., Alterio, T., Sciveres, M., & Maggiore, G. (2023). Juvenile Autoimmune Hepatitis: Recent Advances in Diagnosis, Management and Long-Term Outcome. Diagnostics, 13(17), 2753. https://doi.org/10.3390/diagnostics13172753

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop